2023/07/03 NEW
Message from appointment Representative Director
2022/06/22 NEW
Our Technology
Business
Clinical development pipeline
Corporate information
Employment opportunities
News
We provide seven exceptional features through
Animal Origin-Free (AOF) medium technology.
Excellent therapeutic efficacy
Secure regenerative medicine with no risk of infections
Efficient cellular medicine development and gene therapy products services
Sustained production of homogeneous cells
Development of “Designed MSCs”
Stable global supply of media
Exosomes and culture conditioned medium
By contributing to the creation of a society full of excitement, we will develop into a company that is said to be of help, making employees and the society happy.
The serum-free nature enables modification of a variety of cellular characteristics.
In addition, a library of chemicals to produce cells with modified characteristics enables selection of the best cells for target diseases.
See more.
A culture system that is free from human / animal-derived components throughout all processes.
This system is characterized by media showing excellent cell growth.
See more.
Our culture conditioned medium, which are characterized by the safety of AOF and high content of exosomes, have proven to be effective in multiple disease animal models. Their use as samples for research will provide strong support for development.
See more.
Clinical trials using AOF medium for intractable diseases requiring regenerative medicine.
Licensing out mainly on the right to develop culture technology and regenerative medicine products.
Consulting on the design, construction, and operation of cell processing facilities for medical institutions that perform regenerative medicine or companies that are entrusted with cell culture.
We create the regenerative medicine, company, and personnel that are admired from around the world. We recruit staff members to work with us.
See more.
BioMimetics Sympathies recruits partners to provide treatment for as many intractable diseases as possible.
See more.